Sarda Proteins Sees Unprecedented Buying Interest Amid Upper Circuit Scenario

Strong Buying Pressure Drives Upper Circuit

On 21 Nov 2025, Sarda Proteins Ltd, a key player in the edible oil sector, recorded a day change of 3.08%, outperforming the Sensex which declined by 0.17% on the same day. The stock opened with a gap down of -4.93% but swiftly reversed course to touch an intraday high of Rs 65, marking a 3.08% gain. Notably, the stock hit a new 52-week low of Rs 59.95 during the session, reflecting significant volatility.

What sets today apart is the complete absence of sell orders, with only buy orders queued up, pushing the stock into an upper circuit. This scenario indicates overwhelming demand from investors and traders, with sellers refraining from offloading shares at current levels. Such a situation often leads to a sustained circuit for multiple sessions, as buying interest continues unabated.

Performance Context: Volatility Amid Long-Term Trends

Examining Sarda Proteins’ recent performance reveals a mixed picture. Over the past week, the stock has shown a decline of 10.12%, contrasting with the Sensex’s 1.10% gain. The one-month performance remained flat at 0.00%, while the three-month period saw a sharp fall of 52.71%, against the Sensex’s 4.26% rise. The one-year trend also reflects a decline of 39.73%, whereas the Sensex advanced by 10.80% in the same timeframe.

Year-to-date, Sarda Proteins has not recorded any price movement, standing at 0.00%, while the Sensex has appreciated by 9.41%. Over a longer horizon, the stock’s three-year performance shows a steep fall of 69.08%, in stark contrast to the Sensex’s 39.82% gain. However, the five-year data presents a remarkable 550.00% increase for Sarda Proteins, significantly outpacing the Sensex’s 94.82% rise. The ten-year performance remains flat at 0.00%, while the Sensex surged by 230.48%.

Technical Indicators and Trading Patterns

From a technical standpoint, Sarda Proteins is trading above its 200-day moving average, which often acts as a long-term support level. However, it remains below its 5-day, 20-day, 50-day, and 100-day moving averages, indicating short- to medium-term resistance. This technical setup suggests that while the stock has some underlying support, it faces challenges in regaining momentum over shorter periods.

Trading activity has been erratic, with the stock not trading on one day out of the last 20 sessions. Such irregularity can contribute to price swings and heightened volatility. The current upper circuit and exclusive buy orders may reflect a shift in market sentiment, potentially signalling a turnaround or a speculative surge.

Sector and Market Comparison

Within the edible oil sector, Sarda Proteins’ performance today outpaced the sector by 3.24%, underscoring the intensity of buying interest relative to its peers. The edible oil industry has experienced varied trends recently, influenced by commodity price fluctuations, supply chain dynamics, and regulatory developments. Sarda Proteins’ unique trading pattern today may be a response to sector-specific factors or company-specific news impacting investor behaviour.

Potential for Multi-Day Upper Circuit

The presence of only buy orders and the upper circuit status often indicate a strong bullish sentiment that may persist over several trading sessions. This phenomenon can be driven by fresh institutional interest, positive developments in company fundamentals, or speculative momentum. Investors should monitor the stock closely for confirmation of sustained demand or any reversal signals.

While the stock’s recent history shows significant volatility and mixed performance, the current buying frenzy could mark a pivotal moment. However, the absence of sellers also means liquidity may be constrained, which can amplify price swings and increase risk for traders entering at elevated levels.

Investor Considerations

Given the unusual trading pattern, investors are advised to exercise caution and consider the broader market context. The edible oil sector’s dynamics, combined with Sarda Proteins’ technical indicators and historical performance, suggest that while opportunities exist, risks remain elevated. Close attention to volume trends, news flow, and sector developments will be crucial in assessing the sustainability of the current buying interest.

In summary, Sarda Proteins’ upper circuit and exclusive buy queue highlight a rare market event underscored by extraordinary demand. Whether this momentum translates into a sustained rally or a short-lived spike will depend on forthcoming market developments and investor sentiment.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →